or
forgot password

    • cancer clinical trials in huntsville, AL

    • A Study to Evaluate rhuMab 2C4 and Gemcitabine in Subjects With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
    Comprehensive Cancer Institute
    Huntsville, Alabama 35801
    Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer
    A Multiple Myeloma Trial in Patients With Bone Metastases
    Hematology Oncology Specialists
    Huntsville, Alabama 35801
    Multiple Myeloma
    OraVescent Fentanyl (OVF) for the Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients
    Center for Pain Management
    Huntsville, Alabama 35801
    Pain, Cancer
    A Comparative Study of Degarelix Three-month Depot in Three Different Dosing Regimens in Patients With Prostate Cancer
    Medical Affiliationed Research Center
    Huntsville, Alabama 35801
    Prostate Cancer
    Remission and Joint Damage Progression in Early Rheumatoid Arthritis
    Rheumatology Associates Of North Alabama
    Huntsville, Alabama 35801
    Rheumatoid Arthritis
    Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site
    Clearview Cancer Institute
    Huntsville, Alabama 35805
    Neoplasms, Unknown Primary
    Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's Disease
    Site Ref # / Investigator 1894
    Huntsville, Alabama 35801
    Crohn's Disease
    Phase II Research Study of Arsenic Trioxide (Trisenox) in Patients With Myelodysplastic Syndrome (MDS)
    Comprehensive Cancer Institute
    Huntsville, Alabama 35801
    Myelodysplastic Syndrome (MDS)
    Protocol for Radiofrequency Ablation of Pulmonary Neoplasms
    Comprehensive Cancer Institute
    Huntsville, Alabama 35801
    Pulmonary Neoplasms
    Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy
    Marshall Schreeder, MD
    Huntsville, Alabama 35801
    Carcinoma, Non-Small-Cell Lung, Lung Cancer, Neoplasms, Lung, Neoplasms, Pulmonary
    Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses
    Medical Affiliated Research Center, Inc.
    Huntsville, Alabama 35801
    Actinic Keratosis
    A Safety and Efficacy Study in Patients With Gastric Cancer
    Clearview Cancer Center
    Huntsville, Alabama 35801
    Gastric Cancer
    Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
    Heart Center, Inc.
    Huntsville, Alabama 35801
    Atrial Fibrillation, Atrial Flutter
    Study of the Optimal Protocol for Methotrexate and Adalimumab Combination Therapy in Early Rheumatoid Arthritis
    Site Reference ID/Investigator# 6222
    Huntsville, Alabama 35801
    Rheumatoid Arthritis
    Assessment and Tracking of Long-term Alefacept Safety
    Ruth A Yates
    Huntsville, Alabama 35801
    Psoriasis
    Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
    Heart Center Research, Llc
    Huntsville, Alabama 35801
    Venous Thrombosis, Pulmonary Embolism
    Diarrhea Predominant Irritable Bowel Syndrome in Females
    Clinical Research Associates, LLC
    Huntsville, Alabama 35801
    Irritable Bowel Syndrome
    Chemoprevention of Colorectal Adenomas
    Alabama Digestive Disorders Center, P.C.
    Huntsville, Alabama 35802
    Adenomatous Polyps
    Tezosentan in the Treatment of Acute Heart Failure
    Oracle Research
    Huntsville, Alabama
    Acute Heart Failure, Acute Decompensation of Chronic Heart Failure, New Onset of Heart Failure
    Molecular Profiling Protocol (SCRI-CA-001)
    Oncology Specialties
    Huntsville, Alabama 35805
    Refractory Cancer
    Safety and Efficacy of Abatacept Versus Placebo in Participants With Psoriatic Arthritis
    Rheumatology Associates Of North Alabama
    Huntsville, Alabama 35801
    Psoriatic Arthritis
    A Phase 2, Double-Blind, Multiple-Dose Escalation Study to Evaluate NKTR-118 (Oral PEG-Naloxol) in Patients With Opioid-Induced Constipation (OIC)
    Tennessee Valley Pain Consultants / Center for Pain Management
    Huntsville, Alabama 35801
    Opioid Induced Constipation (OIC)
    Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women
    BioSante Site #014

    Trial Locations
    BioSante Site #014
    BioSante Site 196
    Hypoactive Sexual Desire Disorder
    Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer
    Clearview Cancer Institute
    Huntsville, Alabama 35805
    Colorectal Cancer
    Drug-Eluting Bead, Irinotecan (DEBIRI) Therapy of Liver Metastasis From Colon Cancer With Systemic FOLFOX6
    Clearview Cancer Center
    Huntsville, Alabama 35801
    Colon Cancer With Metastases to the Liver
    Imetelstat in Combination With Paclitaxel (With or Without Bevacizumab) in Patients With Locally Recurrent or Metastatic Breast Cancer
    Clearview Cancer Center
    Huntsville, Alabama 35801
    Locally Recurrent or Metastatic Breast Cancer